Inmune Bio Inc. logo

Inmune Bio Inc. (INMB)

Market Closed
16 Oct, 08:00 PM
NASDAQ (CM) NASDAQ (CM)
$
1. 57
-0.08
-4.8485%
$
50.25M Market Cap
- P/E Ratio
- Div Yield
196,200 Volume
-2.19 Eps
$ 1.65
Previous Close
Add Transaction
Day Range
1.56 1.68
Year Range
1.09 2.6
Want to track INMB and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Inmune Bio Inc. Investors

Name Quantity Cost Value Profit ($) Gain (%)
Curtis Ellergodt
Curtis Ellergodt Rothschild Investment LLC
310 $350.27 $511.5 $161.23 46.03%
NA
Nizar Araji National Bank Of Canada /FI/
2,000 $2,560 $3,300 $740 28.91%
Point72 Asset Management LP
Point72 Asset Management LP Point72 Asset Management LP
16,577 $21,218.56 $27,352.05 $6,133.49 28.91%
Jeffery Yorg
Jeffery Yorg Focus Partners Advisor Solutions LLC
43,556 $118,175.14 $72,302.96 -$45,872.18 -38.82%
Bobby Adusumilli
Bobby Adusumilli SJS Investment Consulting Inc.
41 $51.13 $67.65 $16.52 32.31%
KB
Kimberly Byrne Bill Few Associates Inc.
10,675 $20,923 $17,080 -$3,843 -18.37%
Hui Fai Tam
Hui Fai Tam Caitong International Asset Management Co. Ltd.
17 $21.31 $28.05 $6.74 31.63%
JWM
JPL Wealth Management LLC JPL Wealth Management, LLC
6 $7.68 $9.9 $2.22 28.91%
Ashley Meredith
Ashley Meredith Abel Hall, LLC
24,559 $31,435.52 $41,136.32 $9,700.8 30.86%
MA
Marie-Andree Alain Federation des caisses Desjardins du Quebec
400 $4,124 $660 -$3,464 -84%
Matthew Okkerse
Matthew Okkerse Dauntless Investment Group LLC
100 $156 $167.5 $11.5 7.37%